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WVHEN injected intravenously or intra-
peritoneally C(orynebacteriunm parvtrm, (C.
parvum) has powerful anti-tumour effects
(Woodruff and Boak, 1966; Halpern et al.,
I 966; Woodruff and Dunbar, 1,973; Smith
and Scott, 1.972; Castro, ]974a). It causes
enlargement of the spleen (Halpern et al.,
1963; Castro, 1974b) and development of
antibodies (Woodruff, McBride and
Dunbar, 1974). Recent work suggests that
given orally in large doses, BCG main-
tains some of the anti-tumour effect seen
after parenteral injection (Falk, Mann and
Langer, 1973). Similarly, antilymphocyte
serum has been shown to prolong skin
allograft survival after oral administration,
(Seifert, Ring and Brendel, 1974). Oral
administration ofdrugs and vaccines would
be advantageous and we therefore studied
the effects of oral C. parvum on tumour
growth, spleen size and antibody form-
ation in mice.
MATERIALS AND METHODS
Age-matched syngeneic female C57/B1
mice (Olac) wl-ere used. Lew-is lung carci-
noma which originated spontaneously as a
carcinoma of the lung of a C57/B1 mouse at
the Wistar Institute in 1951 (Sugiura and
Stock, 1955) was implanted subcutaneously
as a 04- ml homogenate in the lower flank.
It is a rapidly growing epidermoid carcinoma
which wAhen implanted subcutaneously meta-
stasizes to the lung (Simpson-Herren, San-
ford and Holmquist, 1974). Cells are released
from the primarytumour6daysafterimplant-
ation (James and Salsbury, 1974) and macro-
scopical metastases are easily, visible 21
days after implantation. Two diameters of
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the primary tumour were measured twice
weekly and the mean diameter calculated.
Macroscopical lung metastases were counted
21 days after tumour implantation, after
staining the lungs by inflation with indian
ink (Wexler, 1966).
A heat killed suspension of C. parvuni
(W'ellcome batch PX374, 7 mg dry weight/ml)
was used. Three groups of mice received
0 *1 ml C. parvum either intravenously (i.v.),
intraperitoneally (i.p.) orsubcutaneously (s.c.)
on the same day as tumour implantation. A
control group was untreated. Oral C. parvumn
wAas administered to a group of 8 mice by
stomach tube on Days 0, 3, 5 and 7 after
tumour implantation, appropriate controls
receiving the same volume of normal saline.
Spleen mass was determined in 2 groups
of 8 mice 21 days after 1 ml oforal C. parvum
or normal saline on Days 0, 3, 5 and 7 by
immediate wreighing of the excised organ on
a torsion balance. The histological appear-
ances ofspleens from such animals were com-
pared by examination of haematoxylin and
eosin stained sections.
Antibodies to C. parvumm were measured
in 2 groups of 10 mice given 1 ml C. parurun
3 times weekly for 4 weeks. Controls were
given appropriate doses of saline. Twelve
days after the last dose of C. parvum the mice
were heavily anaesthetized with ether and
exsanguinated from the retro-orbital sinus.
The serum was stored at -20°C and anti-
bodies to C. Parruvn measured a week later
by a passive agglutination technique. Doub-
lingdilutions ofserum wNeremade inphosphate
l)uffered saline to a total volume of 0 *2 ml in
each tube. (If insufficient serum was avail-
able from individual mice, sera from 2 mice
were pooled.) An equal volume ofC. parruani
diluted to the same opacitv as Browin's tube
2 (WN'ellcome) was added to the serum samples.T. E. SADLER AND J. E. CASTRO
Positive and negative controls were included
in the test. The mixtures were incubated
for 2 h at 37°C and then at 4°C for 24-48 h.
Agglutination was observed and the results
expressed as titres.
RESULTS
The anti-tumour effects of 0 1 ml C.
parvrtm administered i.v., i.p. or s.c. and
given on the same day as tumour inocu-
lation were studied in 3 groups of 9 mice.
When compared with a group of 9 un-
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treated control mice, i.v. or i.p. injection
of C. parvtm reduced the growth and
weight of the primary tumour (Fig. 1)
and the number of pulmonary metastases
were less (Table I). There was no sig-
nificant effect of subcutaneous C. parvum
on tumour size or metastases.
A dose of 1 ml of C. parvrnm given
orally to 8 mice, 0, 3, 5 and 7 days after
tumour inoculation had no effect upon the
primary tumour (Fig. 2) or on the number
of pulmonary metastases (Table II) when
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FIG. 1.-Effect, of C. parvumer given i.v., i.p. or s.c. on the growth of the primary Lewis lung tumour.
Each point represents the mean of 9 mice and I denotes the stanclard error.
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TABLE 1.-The Effect of C. parvum Given i.v., i.p. or s.c. on Pulmonary Metastases
from Lewis Lung Tumour
Treatment
Controls-untreated
C. parvum i.v.
C. parvum i.p.
C. parvum s.c.
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Mean no. of Range of
No. of animals metastases metastases
9 24 10-37
9 4 0-li
9 4 0-8
9 18 7-36
P value
0-001
0.001
0 7
I I I I I I I
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FIG. 2.-Effect of C. parvum given orally on the growth of the primary Lewis lung tumour. Each
point represents the mean of 8 mice and I denotes the standard error.
TABLE II.-The Effect of Oral C. parvum on Pulmonary Metastases
from Lewis Lung Tumour
Treatment
Oral normal saline
Oral C. parvum
Mean no. of Range of
No. of animals metastases metastases
8 35 21-50
8 37 17-56
P value
0 7
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TABLE II1.-The Effect of Oral C. parvum on Spleen lW'eight
Spleen wvt Ranige
Treatmenit No. of animals (mg) (mg) P valtue
Oral inormal saline 8 94 84-11()
Oral C. parvuom 8 97 78-117 0 ()
compared witlh mice given oral normal
saline in the same dose. Oral C. parvumn
had no significant effect upon spleen size
when compared with controls (Table III)
and the histological appearances of the
spleens from these 2 groups of mice were
similar.
The antibody titre to (C. parvum in
mice given i.v. (1* parvum was>1024. In
mice given oral saline or C. parvurnt there
was Ino significant difference in antibody
titre, wAhich ranged from 32 to 1024.
DISCUSSION
Intravenous or intraperitoneal C. par-
vunt inhibited growith of the primary
Lewis lung tumour and its metastases.
This confirms the anti-tumour activity
of C(. parvurn observed in other animal
tumours (Woodruff and Boak, 1966);
Halpern etal., 1966; Woodruffand Dunbar,
1973; Smith and Scott, 1972; Castro,
1974a). No protective effect of C. parvurni,
was observed when the same dose of C.
parvumn was given subcutaneously and
this confirms the inferior anti-tumour
effects of the vaccine when given by this
route (Woodruff and Inchley, 1971
Woodruff, Inchley and Dunbar, 1972).
Further, there was no anti-tumour effect
of oral C(. patvum despite the fact that
the total dose given was 40 times that
which had powerful anti-tuimour effects
when administered i.v.
Spleen mass of mice given (7. parvunr
i.v. or i.p. is increased 6-7-fold when
compared with untreated controls (Castro,
1 974b) and there is a concomitant increase
of mnacrophage function (Halpern et al.,
1963). When (. parvum was given orally
in the same large dose there was no in-
crease in spleen size.
WhenIC. parvurn is giveIn i.v. or i.p.
antibodies develop against it, both in
laboratory animals and humans. Mice
given 0 1 ml C(. parvurtn i.v. showed an
antibody titre greater than 1024. In mice
given a total dose 120 times greater than
the i.v. dosage there was no significant
difference in effect from that in control
mice receiving saline.
The observations that (. parvurm given
orally does not initiate antibodies against
itself, does not increase spleen size and
does not have ananti-tumoureffect against
the Lewis lung tumouir in mice suggest
that it is not absorbed intact across the
gut wall. Therefore, we conclude that
administration by this route is ineffective
and will have no application to clinical
practice.
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